Is SpaceX Under $160 a Bargain or a Trap?

SpaceX’s IPO priced at $135 per share on June 12 raised $85.7B and valued the company at $1.77T, but the stock has been volatile—up 16.7% vs. its listing price yet down ~30% from a ~$225.64 mid-June high (at ~$157.54 on July 1). Fundamentals are mixed: revenue rose 33% YoY to $18.7B, but SpaceX posted an estimated ~$4.9B net loss last year and is expected to widen losses as its AI infrastructure build ramps. Despite an Alphabet AI contract starting in October ($920M/month; ~$3.2B in AI sales in 2025) and potential growth from Starlink/launches, the article flags significant insider selling risk (about $800B of holdings becoming eligible between now and October), portraying the stock as “closer to a trap than a bargain” rather than a clear buy under $160.

Analysis

The tradable variable here is not near-term revenue; it is float. A newly public mega-cap with a still-evolving ownership structure often trades on scarcity until the first meaningful wave of secondary supply clears, and that tends to cap upside more than operating results do. The setup favors volatile price action for weeks, but the medium-term risk is that supply shows up faster than incremental fundamental buyers.

Second-order winners sit in the compute stack, not necessarily in the end customer. If AI infrastructure spend is accelerating, the first beneficiaries are the GPU, networking, power, and cooling vendors that monetize capex immediately, while the platform company itself absorbs the cash burn before the market can prove monetization. Alphabet is only a modest beneficiary unless the contract turns into a durable, margin-accretive revenue stream; one large agreement does not move a trillion-dollar balance sheet on its own.

The bearish consensus may be slightly too focused on headline valuation and not enough on financing math. The bigger risk is widening losses plus insider monetization into a thinly traded public float, which can create drawdowns even if the business is executing. The thesis is falsified if the post-lockup tape stays tight, secondary supply clears without discount, and October-related AI revenue becomes visible enough to support a higher run-rate multiple.

Key Decisions for Investors

• If borrow/liquidity is workable, initiate a small short SPCX or buy an Oct/Nov 150/130 put spread on any strength; this expresses the insider-supply overhang with defined risk. Cut if SPCX reclaims the prior high on volume and holds there for several sessions.
• Pair trade: long NVDA / short SPCX for 1-3 months to express the view that AI capex accrues more reliably to the supplier stack than to the richly valued end-user. Risk: any early proof of monetization or strategic buying in SPCX can squeeze the short leg sharply.
• Keep GOOGL neutral-to-slightly positive, but only add on weakness if earnings confirm AI spend is not impairing margins. This news alone is not enough to justify a standalone long.
• Watch the October-to-November window for secondary prints or lockup releases; if supply clears cleanly and volatility compresses, reassess the short case rather than fighting the tape.